A new study published in the Lancet medical journal on Friday has found hydroxychloroquine, the anti-malaria drug U.S. President Donald Trump said he’s been taking, could be linked to a higher death rate in COVID-19 patients. The study cautioned against using the drug to treat COVID-19 outside of clinical trials until there is conclusive data on the drug’s safety and efficacy. It was also not found to have any added benefit for COVID-19 patients, according to the study.
Health
Coronavirus outbreak: Study finds hydroxychloroquine may be tied to higher fatality risk for COVID-19 patients
More Videos
-
Organic carrots recalled over E. coli outbreak
-
Business Matters: Carrot recall expands to Canada
-
Organic carrots sold in Canada, U.S. recalled in deadly E.coli outbreak
-
Trees of Joy campaign kicks off for Make-A-Wish Canada
-
Boost your happiness with gratitude this November
-
Health Matters: New Delhi pollution levels hit 50 times the safe limit
You are viewing an Accelerated Mobile Webpage.
View Original Article